484 related articles for article (PubMed ID: 36362014)
1. Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery.
Dasram MH; Walker RB; Khamanga SM
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362014
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts: a nexus for endocannabinoid signaling?
McFarland MJ; Barker EL
Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
[TBL] [Abstract][Full Text] [Related]
4. Targeting the endocannabinoid system: future therapeutic strategies.
Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
[TBL] [Abstract][Full Text] [Related]
5. Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease.
Cairns EA; Toguri JT; Porter RF; Szczesniak AM; Kelly ME
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):253-65. PubMed ID: 26565550
[TBL] [Abstract][Full Text] [Related]
6. Structural and Functional Insights into Cannabinoid Receptors.
Li X; Shen L; Hua T; Liu ZJ
Trends Pharmacol Sci; 2020 Sep; 41(9):665-677. PubMed ID: 32739033
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system.
Kilaru A; Chapman KD
Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
[TBL] [Abstract][Full Text] [Related]
8. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid system and mood disorders: priming a target for new therapies.
Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
Vemuri VK; Janero DR; Makriyannis A
Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
[TBL] [Abstract][Full Text] [Related]
11. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
Karimian Azari E; Kerrigan A; O'Connor A
J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.
Navarro-Romero A; Galera-López L; Ortiz-Romero P; Llorente-Ovejero A; de Los Reyes-Ramírez L; Bengoetxea de Tena I; Garcia-Elias A; Mas-Stachurska A; Reixachs-Solé M; Pastor A; de la Torre R; Maldonado R; Benito B; Eyras E; Rodríguez-Puertas R; Campuzano V; Ozaita A
Elife; 2022 Oct; 11():. PubMed ID: 36217821
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.
Bright U; Akirav I
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628337
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain.
Greco R; Demartini C; Zanaboni AM; Francavilla M; De Icco R; Ahmad L; Tassorelli C
Headache; 2022 Mar; 62(3):227-240. PubMed ID: 35179780
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid System Components: Overview and Tissue Distribution.
Joshi N; Onaivi ES
Adv Exp Med Biol; 2019; 1162():1-12. PubMed ID: 31332731
[TBL] [Abstract][Full Text] [Related]
17. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
Onaivi ES
Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
[TBL] [Abstract][Full Text] [Related]
19. Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systems.
Janero DR; Makriyannis A
ACS Chem Neurosci; 2014 Nov; 5(11):1097-106. PubMed ID: 24866555
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system and its therapeutic exploitation.
Di Marzo V; Bifulco M; De Petrocellis L
Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
